Lipopolysaccharide-preconditioned mesenchymal stem cell transplantation attenuates critical persistent inflammation immune suppression and catabolism syndrome in mice
Conclusions: MSC1s can protect mice against critical PIICS, partly by enhancing CD8+ T-cell function. Therefore, MSC1 transplantation is a novel therapeutic candidate for PIICS.
Source: Shock - Category: Emergency Medicine Tags: Basic Science Aspects Source Type: research
More News: Emergency Medicine | Health Management | Science | Stem Cell Therapy | Stem Cells | Study | Transplants | Weight Loss